Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
"Because declines in acetyl-L-carnitine and free carnitine tracked closely with the severity of Alzheimer's disease, the molecular pathways involved in their production offer other possible ...
NEW YORK, Jan. 8, 2025 /PRNewswire/ -- Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer's disease, particularly in women. Levels were ...